Corona Virus
Stay Safe, FollowGuidance
Fetching Location Data…
James Hyerczyk
US Stock Market Volatility

Blame the Fed, blame the election, blame overpriced technology stocks, but with multiple companies set to go public in the coming week, there could be new reasons for volatile trading.

CNBC’s Jim Cramer is warning that investors be cautious about how they approach the market given the number IPOs in the near future. It all comes down to competition for the investment dollar. Investors want to participate in the new issues, but in order to do this; they may be forced to sell current holding to raise the cash.


“When we get a flood of initial public offerings, it’s usually a bad sign for the rest of the market,” Mad Money host Cramer said last week, “because money managers don’t have all this new money coming in, so they’ve got to sell holdings that are like these stocks in order to do some buying.”

Wall Street has seen more than 110 companies go public thus far in 2020, up 5% from this point last year, Cramer pointed out.

“Given that September trends to be a bad month for the market, he said, “I’m urging you to be prepared as these deals start flowing.”

Cramer’s Take on Current and Upcoming IPOs

  • Snowflake:  “This thing’s going to be too red hot, unless you can get a piece of the actual deal, which would be fantastic,” he said. “It might be too expensive otherwise.”
  • Unity Software:  “Not yet profitable.”
  • JFrong:  “This is one of the most lucrative corners of the cloud-based software space.”
  • Sumo Logic:  “I’m not familiar with this one, but what matters here is that you’ve got four cloud deals coming next week, and that causes some portfolio managers to sell current cloud holdings [because] they have to make room for the new ones.”
  • Amwell:  “Given that Teledoc’s merging with Livongo, the digital health coach, Amwell could slot right into the market as the only publicly traded pure play on telemedicine. That said, it’s still far from profitable.”
  • GoodRx:  “At a time when people are paying close attention to their health and their bank accounts, GoodRx seems like a winner. Again, though, it all depends on price – you don’t want to buy something that comes in too hot.”
  • Palantir (direct listing):  “Palantir’s a rapidly growing business, so it just might work, although recent reports suggest that the early interest hasn’t been as strong as the company or anybody else expected, for that matter.”
  • Asana (direct listing):  “Asana’s got a terrific growth rate – 82% in its most recent fiscal year, very few have that – but it’s also a consistent money loser. I think it’ll be a good test case for what this market values.”

Snowflake Update

Shares of Snowflake closed down 10.39% Thursday, a day after the cloud company’s blockbuster market debut.

It’s a sharp drop from Wednesday’s close, when shares were up more than 111%, giving Snowflake a $70.4 billion market capitalization. The company’s market cap dropped to $63.1 billion at Thursday’s market close.

Snowflake raised more than $3 billion based on its opening price, the most ever for a software company. The stock trades under the symbol SNOW.

Unity Software Prices IPO Above Range at $52

Video game software developer Unity priced its IPO above the expected range on Thursday in an offering that initially values the company at $13.7 billion, CNBC has confirmed.

Unity sold shares at $52 apiece, after lifting the range on Wednesday to between $44 and $48. Reuters was first to report on pricing.

For a look at all of today’s economic events, check out our economic calendar.
Don't miss a thing!
Discover what's moving the markets. Sign up for a daily update delivered to your inbox

Trade With A Regulated Broker

  • Your capital is at risk
The content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your own due diligence checks, apply your own discretion and consult your competent advisors. The content of the website is not personally directed to you, and we does not take into account your financial situation or needs.The information contained in this website is not necessarily provided in real-time nor is it necessarily accurate. Prices provided herein may be provided by market makers and not by exchanges.Any trading or other financial decision you make shall be at your full responsibility, and you must not rely on any information provided through the website. FX Empire does not provide any warranty regarding any of the information contained in the website, and shall bear no responsibility for any trading losses you might incur as a result of using any information contained in the website.The website may include advertisements and other promotional contents, and FX Empire may receive compensation from third parties in connection with the content. FX Empire does not endorse any third party or recommends using any third party's services, and does not assume responsibility for your use of any such third party's website or services.FX Empire and its employees, officers, subsidiaries and associates, are not liable nor shall they be held liable for any loss or damage resulting from your use of the website or reliance on the information provided on this website.
This website includes information about cryptocurrencies, contracts for difference (CFDs) and other financial instruments, and about brokers, exchanges and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and come with a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money.FX Empire encourages you to perform your own research before making any investment decision, and to avoid investing in any financial instrument which you do not fully understand how it works and what are the risks involved.